Genitrix has reformulated and repackaged its Lacto B range of broad spectrum probiotic supplements for the maintenance of normal digestive function in pets.
The products are provided in a powder formulation for direct application onto food or to be dissolved in water. They are available in five-day sachets or in 75g tubs suitable for longer term use.
Genitrix says that unlike single-strain formulations, the Lacto B range contains live freeze-dried cultures of three probiotic organisms which, when ingested, colonise the gut, helping to re-establish normal function. The three strains of probiotic organisms occupy the same sites in the gut as certain pathogenic bacteria thus preventing their attachment.
Indicated for dogs, cats, rabbits, rodents, reptiles and birds, the Lacto range is formulated to provide a guaranteed concentration of 1x109 CFU/g probiotic organisms.
Genitrix suggests that the Lacto B range can be particularly helpful in:
Rob Watkins, Marketing Director at Genitrix, said: "The Lacto range has been tried and trusted in small animal practice for twelve years and feedback shows that its multi-species indication make it a flexible and cost-effective solution."
"With its new formulation and new packaging, we believe it will prove even more attractive as a high potency probiotic supplement."
For more information, please click here.
Lizzie joined the College as Head of Communications in February 2005, in which role she oversaw the launch of the Practice Standards Scheme in 2006, an overhaul of the College’s design and branding in 2011 and the joint British Veterinary Association Vet Futures project in 2014. More recently, she has been the driving force behind the Mind Matters mental health initiative.
Lizzie was appointed as Director of Strategic Communications in November 2015 and Deputy CEO in September 2016. She became Acting CEO when Nick Stace left the position of CEO at the end of September 2017.
The College advertised the position in the Sunday Times online for four weeks, and used a recruitment agency called Saxton Bampfylde. In all, 60 candidates applied.
RCVS President Professor Stephen May said: "This was a very rigorous recruitment process with a very strong field of candidates and so it is a testament to Lizzie’s abilities and achievements that she saw off all the opposition.
"For some time Lizzie has been involved in setting the direction of the College through the Strategic Plan and the initiatives and projects that she has managed, which really have had a very tangible impact on the profession.
"For example, the Vet Futures project has encouraged the profession to think more strategically about the issues that are facing it and how to achieve constructive solutions, while the Mind Matters Initiative has helped get veterinary mental health further up the agenda and reduced the stigma that many feel about it.
"Her drive and her passion has really pushed these projects forward and I believe she will bring this to the role of CEO.”
Lizzie said: "I am delighted and feel honoured to have been chosen to take the College forward into its next stage of development. I see the Council’s choice of an internal candidate, able to maintain momentum for change and help the College continue on our current strategic path, as an endorsement of the amazing work of the staff at Belgravia House.
"Under Nick Stace’s leadership, the College achieved some really excellent things for the profession, the public, and animal health and welfare, and I look forward to our next exciting chapter."
PawSquad, which was founded in 2015 by Diwaker Singh and Radu Georgescu, offers veterinary consultations by video and live text chat in the United Kingdom. IVC says it continue to operate as an autonomous entity within the IVC group.
PawSquad CEO, Dr Mark Boddy MRCVS (pictured right) said: “Our network of experienced veterinarians has already helped many thousands of pets in the UK, providing medical advice, emergency triage and preventive health plans. Being part of IVC will allow us to help even more pets and to continue to work positively and collaboratively with the veterinary profession, as well as expand geographically.”
Stuart Caton, Chief Commercial Officer at IVC Evidensia said: "Telemedicine will support the efforts of the group to make high quality veterinary care more accessible to pet owners, lowering the barriers to engagement with the veterinary profession. It’s an excellent acquisition that will further complement the group as pet services grow and evolve in the future. We are delighted the entire PawSquad team will continue with the business supporting their corporate and private clients as before.”
IVC says the accessibility of the PawSquad service encourages pet owners to seek professional advice earlier and more frequently, with around half of all queries being referred for necessary in-clinic follow-up and otherwise providing much valued reassurance and peace of mind.
The company also says telemedicine is particularly appreciated by cat owners or those with nervous dogs, where the stress of a clinic visit can sometimes result in those pets missing out on veterinary care.
PawSquad Chairman and Founder, Diwaker Singh said: “We are pet lovers and launched PawSquad with the objective of making sure that pet owners have instant 24/7 access to quality pet care, accessible from their homes. Towards this end, PawSquad is a great success. The service has grown significantly, confirming there is a clear need for this service. IVC Evidensia’s extensive network will help the business strengthen and grow to even greater heights.”
The study was the first to use prospectively collected data to estimate the prevalence of and risk factors for gingivitis in a cohort of domestic cats, using data from 860 cats aged up to six years enrolled in the Bristol Cats Study. Gingivitis was found to be a common condition in cats aged up to six years, with prevalence increasing with age, from 24.5% in cats less than 12 months old, up to 56.3% in cats between five and six years old. Odds of gingivitis in cats aged three to four years were higher in cats fed a wet only or mixed wet/dry diet compared to those on a dry only diet; cats not reported to hunt prey compared to reported hunters; cats reported to dribble whilst being stroked at age six months compared to reported non-dribblers; and cats with orange variants in their coat colour compared to non-orange cats. Sex was not found to be a risk factor for gingivitis (Ed's note: what a relief). Jess Williams, lead author of the study, said: “Periodontal disease is one of the most common conditions in cats, potentially causing issues with eating and behaviours like grooming.
"Our study showed that even young cats may have signs of gingivitis, so it is important to discuss and monitor dental health regularly and early on in a cat’s life, especially for those cats who may be more at risk.”
The study was funded by BSAVA PetSavers.
https://onlinelibrary.wiley.com/doi/full/10.1111/jsap.13737
Skin diseases and palpable masses are a common presentation in guinea pigs brought for veterinary care2.
However, few studies have thus far looked at the prevalence of spontaneously arising diseases in pet guinea pigs.
"Lumpy bumpy guinea pigs: a retrospective study of 619 biopsy samples of externally palpable masses submitted from pet guinea pigs for histopathology" retrospectively analysed 619 biopsy samples submitted for histopathology from pet guinea pigs that had presented with externally palpable masses.
The purpose was to determine the most common tissue origins of these masses and the most frequent pathological diagnoses, together with signalment data for the most commonly diagnosed lesions.
Of the 619 samples submitted from 493 animals, 54 (8.7%) had arisen from the mammary glands3 and 15 (2.4%) from the thyroid glands, with the remaining 550 (88.9%) involving the skin and subcutis, muscle (n = 1), salivary glands (n = 4), lips (n = 2), ears (n = 4) and peripheral lymph nodes (n = 23).
Forty-seven (7.6%) of the masses were diagnosed as inflammatory in nature, including dermatitis, panniculitis, lymphadenitis, cheilitis, myositis, sialoadenitis, abscess and chronic inflammation with osseous metaplasia.
Non-neoplastic, non-inflammatory lesions accounted for a further 31 (5.0%), namely cysts, hamartomas, hyperplastic lesions, polyps, ectopic bone formation and salivary gland steatosis.
The remainder of the samples were neoplastic in nature (541; 87.4%), with 99 masses classified as epithelial in origin, 347 as mesenchymal, 23 as round cell, five as melanocytic and eight as unclassified malignant neoplasms.
Of these, mesenchymal neoplasms were further subdivided into benign (288) and malignant (59).
Lipomas were the most common neoplasm diagnosed, accounting for 286 of all samples submitted.
Of all 619 samples included in the study, the eight most commonly diagnosed lesions were lipoma (46.2%), trichofolliculoma (12.3%), sarcoma (of various subtypes: 9.5%), inflammation (all sites 7.6%), lymphoma / leukaemia (3.4%), mammary carcinoma (4%), mammary adenoma (3.2%) and thyroid carcinoma (1.5%).
Overall these eight diagnoses accounted for 87.7% of all submissions from the externally palpable masses from the pet guinea pigs submitted for histopathology.
Melanie said: “Guinea pigs are an increasingly popular household pet.
"Skin diseases, including palpable masses, are a common reason for veterinary presentation. But few studies have been published to date that provide information for clinicians about these conditions.
“This study illustrates the importance of neoplasms of the skin and subcutis in pet guinea pigs, with over 87% of the cases analysed having one of eight diagnoses.
"While most of these neoplasms are benign, a substantial minority are malignant and identifying those lesions is especially important in treatment planning.
"Clinicians dealing with pet guinea pigs should also be aware that some externally palpable masses may arise from the thyroid or mammary glands rather than the skin or subcutis, and that male guinea pigs may also develop mammary lesions.”
The paper has been selected as ‘Editor’s Choice’ by the Journal of Comparative Pathology and will be free to access until September on Lumpy, bumpy guinea pigs: a retrospective study of 619 biopsy samples of externally palpable masses submitted from pet guinea pigs for histopathology - ScienceDirect.
References
The procedure was performed in Canada through an international collaboration between partners from Germany, Canada and the UK, who say that this was a case where the placement of the tumour made it impossible to operate without severely impacting the dog’s quality of life. The most suitable treatment was a total excision of the growth and reconstruction with an implant.
The implant was designed with medical CAD tools by German company, Voxelmed, using 3D imaging from the affected area. The dog's veterinary surgeon, Julius Liptak, contributed to the design to ensure it met specifications and allowing him to plan the procedure in advance.
UK company Renishaw then additively manufactured the patient specific implant (PSI) at the Additive Design In Surgical Solutions (ADEISS) Centre in London, Ontario, Canada.
Ed Littlewood, Marketing Manager at Renishaw’s Medical and Dental Products Division said: "Without the advancements in additive manufacturing technology, this dog would not have had such a long and happy future ahead of him.
"Prior to this case, many veterinary surgeons were unaware that the technology was available. Similar procedures are now being planned in Germany and further research is underway to see how animals can benefit from additively manufactured PSIs.
Jan Klasen, veterinary surgeon, 3D designer and CEO of Voxelmed said: "Without AM technology, it would have been almost impossible to reconstruct the dog’s maxilla after tumour removal, because the area was extremely complex in geometry. The implant had to have a similar shape and functionality as the dog’s existing bone structure.
"Using additive manufacturing to maintain the original shape and function of the oral and nasal cavity ensures a high quality of life for the dog, just as a naturally shaped skull and maxilla helps the dog to breathe and eat easily."
To read the full case study, visit http://www.renishaw.com/en/additive-manufacturing-in-veterinary-surgery-saving-a-well-loved-member-of-the-family--42950.
Vetoquinol UK Limited has launched Kefloril, containing 300mg/ml florfenicol for use in cattle and pigs in 100ml and 250ml vials.
In cattle, Kefloril is licensed for preventative and therapeutic treatment of respiratory tract infections. In pigs, Kefloril is licensed for the treatment of acute outbreaks of respiratory disease. Kefloril has the added benefit of traceability stickers which are attached to each vial, designed to make it easier and quicker to record and monitor on-farm usage.
Vetoquinol says the addition of Kefloril to its anti-infective domain provides a cost-effective treatment for respiratory cases this winter.
This, says the government, would be one of the toughest sanctions in Europe, strengthening the country's claim to be a global leader on animal welfare.
The Animal Welfare (Sentencing) Bill comes after a public consultation held last year which found that more than 70% of people supported proposals for tougher prison sentences. It will allow the courts to take a tougher stance on things like dog fighting, puppy and kitten abuse, and neglect of farm animals.
The new Bill has been welcomed by animal welfare charities.
Chief Executive for the RSPCA, Chris Sherwood, said: "This reform is long overdue. Those responsible for extreme cruelty towards animals or those criminal gangs involved in organised animal crime will now face the tough justice they deserve.
"We need to better protect our animals and the RSPCA hopes that this new Animal Welfare (Sentencing) Bill will give courts the powers they need to punish those responsible for the most unimaginable cruelty to animals.
"We also believe this will act as a much stronger deterrent to others and help us stamp out animal cruelty once and for all."
James Yeates, Cats Protection’s Chief Executive said: "We very much welcome this announcement which is an important step in ensuring the UK is one of the world leaders on animal welfare issues.
Claire Horton, Chief Executive of Battersea Dogs & Cats Home, said: "The introduction of this bill is a landmark achievement, which will make a profound difference to dogs and cats in England and Wales."
The urinary products, which are made to provide tailored nutritional solutions for cats and dogs with urinary issues, are available in both wet pouches and dry kibble.
The company simultaneously introduced a new urinary diagnostic tool: the Royal Canin Hematura Detection by Blücare.
The tool is made up of granules which are put in a cat’s litter tray and which turn blue if they detect blood in the urine. Royal Canin says it is a revolutionary diagnostic aid that will be able to prevent feline lower urinary tract disease developing any further.
John O’Connor, Corporate Affairs Director at Royal Canin, said: "We are constantly looking to evolve our offer and provide the very best in nutrition. We have simplified our ranges making it easier to navigate and choose the right product for each cat and dog, created a new premium pack design and developed our best veterinary nutritional solutions.
"It was imperative that we worked very closely with the veterinary community in making this bold transformation so we consulted with vets and vet nurses, in addition to pet owners from across the world."
Running throughout October, the campaign is designed to raise awareness among dog owners of how Adaptil Calm can help dogs cope during the fireworks and Christmas party season.
The advertising campaign will target 3.3 million pet owners and it will air on over 60 channels including C4 channels (Channel 4, E4, More4, Film4, Drama, Good Food, Really, W and Home), Sky channels, ITV2 and ITVBe.
Abigail King, behaviour product manager at Ceva Animal Health, said: "The fireworks and party season can be an extremely upsetting time of the year for the nation’s pets.
"By highlighting the benefits of Adaptil at this key time of the year we hope to ensure that dogs are better prepared for the challenges of fireworks and loud noises."
Ceva says the TV advertising campaign will be supported by a digital campaign for both Adaptil and Feliway.
To watch the Adaptil TV advertisement visit https://www.adaptil.com/uk/Success-Stories/Finley.
The first charge related to his conviction on two counts of common assault by beating two individuals at an incident in December 2016, as a result of which he was made subject to a community order and a restraining order, as well as being fined and made to pay a victim surcharge and costs.
The second charge related to him undertaking, or attempting to undertake non-emergency surgery on the eyelid of one of the individuals referred to in the first charge, and administering, or attempting to administer, a Prescription-Only Veterinary Medicines to the same person.
The third charged related to an allegation that he had supplied the same individual with a Prescription-Only Medication other than in accordance with a valid prescription.
The second charge and third charges related to incidents which occurred some considerable time before the assault, not as a consequence of it.
At the outset of the hearing Mr Sutcliffe admitted the first and second charges against him and that these constituted serious professional misconduct. He denied the third charge. In relation to that charge the Committee found that, having considered the totality of the evidence, it was unable to be sure that the College had proved the allegation to the requisite standard of proof, namely so that the Committee was sure. Accordingly Charge 3 was dismissed.
The Committee decided that the convictions in the first charge rendered Mr Sutcliffe unfit to practise veterinary surgery and that his conduct in Charge 2 constituted serious professional misconduct.
The Committee then went on to consider sanction.
The Committee considered the aggravating features for both charges. For the first charge it considered the actual injury to one of his victims and risk of injury to the other, noting also that both of his victims were vulnerable people and one was a child, and that the overall incident during which the assaults occurred lasted over a seven hour period.
For the second charge, aggravating factors were that the non-emergency surgery performed by Mr Sutcliffe was wholly inappropriate, that there was a risk of injury to the individual on whom he performed the surgery and that his conduct was reckless.
The mitigating factors considered by the Committee were that Mr Sutcliffe recognised the gravity of the findings against him and demonstrated insight into the allegations, that the incident in charge 1, though prolonged, was an isolated one, that the incident in charge 2 was consensual and did not result in actual harm and that neither charge had any connection with Mr Sutcliffe’s veterinary practice, nor did they affect client care or animal welfare.
Professor Alistair Barr, chairing the Committee and speaking on its behalf, said: "As recognised by the Committee, the respondent has displayed insight as to the seriousness of his behaviour. Having regard to the evidence of all the character witnesses and the written testimonials the Committee accepts that the respondent’s conduct as set out in charges 1 and 2 was wholly out of character and, therefore, there is no significant risk of repeat behaviour. The Committee considers that the respondent would be fit to return to practise, having regard to his excellent track record as a veterinary surgeon to date, after any period of suspension.
"Having regards to the aggravating and mitigating factors in this case, the Committee has decided that it is sufficient to maintain public confidence in the profession and declare and uphold proper standards of conduct to give a direction for suspension of the respondent’s name from the Register of Veterinary Surgeons.
"The Committee considers that the period of suspension must be sufficient to mark the seriousness of the charges but must be proportionate and fair in the circumstances of the case. The Committee has therefore concluded that the appropriate period of suspension is six months."
Mr Sutcliffe has 28 days from being informed of the Committee’s decision to appeal to the Privy Council.
Evidence-Based Veterinary Medicine Matters: Our Commitment to the Future represents the first time that such a broad and influential group has united in support of a single issue in the veterinary profession.
The publication contains a number of case studies which illustrate the impact that evidence can have – and has had – on animal health and welfare. It also provides a rationale for veterinary professionals to contribute to the evidence base and put evidence into practice, to the benefit of animals, owners and veterinary teams themselves.
The signatories to the commitment are:
Animal and Plant Health Agency
British Cattle Veterinary Association
British Equine Veterinary Association
British Small Animal Veterinary Association
British Veterinary Association
British Veterinary Nursing Association
RCVS Knowledge
Royal College of Veterinary Surgeons (RCVS)
Royal Veterinary College
University of Bristol
University of Cambridge
University of Liverpool
University of Nottingham
University of Surrey
Veterinary Policy Research Foundation
No sign of the BAHVS, I see.
Jacqui Molyneux, Chair of the Board of Trustees of RCVS Knowledge, said: "Evidence-Based Veterinary Medicine Matters is a milestone publication for the professions, representing the first time the majority of the key institutions have aligned under the same EBVM banner.
"A celebration of decades of incredible discoveries, achievements and improvements in animal health, it also serves to remind us that even the earliest forms of veterinary medicine were underpinned by evidence."
UK Chief Vet Christine Middlemiss said: "What’s the evidence? An evidence-based approach is vital in all areas of our profession, whatever is keeping you awake at night. For me, it is the threat of African swine fever and avian flu. The evidence I rely on comes from our specialist surveillance monitoring and testing, veterinary epidemiologists and disease modellers. It enables me to make timely, proportionate risk-based decisions that stand up to scrutiny.
"If you are managing veterinary care in practice, the evidence you rely on to underpin your standards of clinical care comes from multiple sources too. Evidence-based veterinary medicine allows us to refine and tailor strategies to be effective and efficient, making full use of existing and new technologies.
"The profession has taken great strides towards embracing evidence-based veterinary medicine and building on this will strengthen the links between clinical decision-making, policy development and future research."
Chris Gush, Executive Director of RCVS Knowledge, added: "We are impressed by the contributions from our co-signatories, which clearly demonstrate the phenomenal impact on patient outcomes that conducting research and using evidence can have. We are also delighted that Sense about Science, a flagbearer for evidence, transparency and rational thinking, has joined with us to highlight the many benefits EBVM can bring.
"The publication also makes a strong case for much-needed funding for research to grow the evidence base, which would put powerful, robust data into the hands of veterinary professionals as they make critical decisions that can affect patient outcomes.
"It is our hope that the calibre, diversity and sheer number of the organisations putting their name to this commitment will galvanise all vets and their teams to expand their use of evidence in practice."
Rebecca Asher, Deputy Director at Sense about Science, said: "This is a showcase of game changers in veterinary care and we hope it will inspire and motivate everyone in the profession.
"We were delighted that RCVS Knowledge approached us to collaborate with them and other leading institutions in the veterinary research community to affirm their commitment to an evidence-based approach to veterinary medicine.
"Everyone expects treatment for humans to be underpinned by evidence. We now expect the same of the whole veterinary community when it comes to the treatment of animals."
The full commitment and portfolio of case studies can be read in Evidence-Based Veterinary Medicine Matters, available for free online: bit.ly/EBVMMatters.
Equibactin oral powder comes in a 60g sachet, which Dechra says is the scientifically considered accurate dose1 for two daily treatments for a 600kg horse. The sachets come in a box of 10, which is sufficient for the twice daily treatment of a 600kg horse for five days.
The combination of sulfadiazine and trimethoprim antibiotics (known as TMPS) has a broad spectrum of uses and can be used to treat equine infections associated with Streptococcus and Staphylococcus aureus, gastrointestinal infections associated with E. coli and urogenital infections associated with beta-hemolytic streptococci.
Emma Jennings, Equine and Food Producing Animal Brand Manager, said: “Our product allows for twice daily 30mg/kg treatments, making the treatment of large horses easier and ensuring they receive the correct dose, which is crucial when it comes to tackling antibiotic resistance.”
She added: “TMPS is the only registered oral antibiotic available for use in horses and it is recommended as the first line of treatment for ‘common’ equine bacterial infections including those which have developed through wound infections or open or drained abscesses.2,3
“Effective antibiotics are an important part of the veterinarian’s arsenal when it comes to treating a variety of common bacterial infections in horses. But in recent years, the emergence of drug resistant bacteria has meant that extra precautions must be taken to prevent underdosing - one of the prominent causes of drug resistance.”
Equibactin oral powder is available now in the UK and Ireland. For more information visit www.dechra.co.uk.
Mark Morton is an RCVS Specialist in small animal orthopaedics, with a particular interest in cruciate ligament injuries: he developed the RCVS Knowledge ‘Canine Cruciate Registry’, of which he remains clinical lead.
Mark has published peer-reviewed papers in the areas of Achilles tendon injury and clinical outcomes measures, as well as pioneering a novel technique to repair Achilles tendon injuries which is now used internationally.
Prior to joining Movement Referrals, Mark has been the lead clinician at a multi-disciplinary referral centre for the last 3 years.
The other Mark, Lowrie, is RCVS and EBVS European Specialist in Veterinary Neurology.
Mark is a global leader in movement disorders in dogs, and has over 50 peer-reviewed articles to his name.
He has also established novel treatment strategies for meningoencephalitis, a common, disabling brain condition of dogs, which has reduced mortality by over 50%.
Mark Morton (pictured) said: “I am delighted to be joining the management team at Movement Referrals.
"I know the rest of the team very well having worked closely with them all before, I can’t think of a better or more experienced team to develop this practice with.
"We aim to provide exceptional care to our patients, with a real focus on the service we provide and the outcomes we achieve”
The two Marks will join the Board of Directors with Ben Walton and Professor John Innes, both RCVS Specialists, and Dr Brian Beale, an ACVS-boarded Specialist in small animal surgery.
Southfields Veterinary Specialists in Laindon, which is part of the Linnaeus Group, has recruited the highly-respected Dr Fabio Stabile to join its neurology and neurosurgery unit.
Fabio will start working at the practice's neurology and neurosurgery unit in January, with another specialist, Dr Ane Uriarte from Tufts University in the USA, joining in the spring.
Fabio said: "I am delighted to be joining Southfields Veterinary Specialists in the new year as a Consultant in neurology and neurosurgery.
"It is an extremely exciting time to be joining Southfields and their team of renowned and successful specialists, especially as this is a strong time of growth in their neurology/neurosurgery discipline.
"The imminent move of the Southfields team to a new, state-of-the-art hospital with the possibility of creating a new phenomenal environment and ‘family’ is really exciting!"
Fabio graduated from Padova University in 2003 before completing a three-year PhD in veterinary clinical sciences at the university supervised by Dr Marco Bernardini DVM, DECVN.
In 2009, he moved to the UK and started a Residency in Neurology and Neurosurgery at the Animal Health Trust under the supervision of Dr Luisa De Risio DVM, FRCVS, PhD, DECVN.
Fabio added: "My main area of interest in veterinary neurology and neurosurgery are epilepsies and the treatment of epilepsy and any neurosurgeries.
"Improving antiepileptic treatment for our patients has constituted my main focus of clinical research. It’s a subject I strongly care about."
Dr Stabile also enjoys passing on the benefits of his expertise and experience to the next generation of veterinary surgeons. He has presented several clinical research abstracts at international and European conferences and he is the author of multiple publications in peer reviewed journal Veterinary Services.
"I have always been extremely keen on teaching and I enjoy delivering lectures to young colleagues in training and to colleagues working in general practice."
For the study, which was conducted in 2018 and published this year in Medical and Veterinary Entomology1, practices from around the UK sent in combings from 812 cats and 662 dogs for analysis.
28% of the cats and 14% of the dogs were found to be carrying fleas, with cats from central Wales and the Welsh Borders being more than twice as likely to have fleas than elsewhere in the country. Likewise, dogs from North Wales, the North Wales borders, South Wales and South West England were between 3 and 4.5 times as likely to have fleas as elsewhere.
Of the cats treated with fipronil, 62% (n=57) were still found to be carrying fleas despite treatment. Of the dogs, 44% (n=49) of those treated with fipronil were still carrying fleas. By contrast, 4.1% of cats and 1.4% of dogs treated with fluralaner (Bravecto) were found to have fleas (the lowest of any treatment).
Professor Richard Wall, Veterinary Entomologist at the University of Bristol said: "There is a clear need for greater owner education about the importance of flea treatment and a better understanding of the efficacy of different flea and tick prevention products.
"It is critical for vets to not only recommend the best product for a pet’s needs but to also give a better understanding of the effectiveness and correct application of the different treatments."
Reference
Photo: Professor Richard Wall, University of Bristol
Vetoquinol UK has launched Sodium Salicyl 80%, a water soluble, non-steroidal anti-inflammatory drug (NSAID).
Sodium Salicyl 80% contains 800mg of sodium salicylate and is indicated for supportive treatment of pyrexia in acute respiratory disease in calves (of at least two weeks of age). In pigs, Sodium Salicyl 80% is indicated for the treatment of inflammation, in combination with concurrent antibiotic therapy. Vetoquinol says that unlike acetylsalicylic acid (conventional aspirin) which is poorly soluble in water, sodium salicylate is highly water soluble (1 g/ml water), even in the hard water commonly encountered in the UK which makes it ideal for group therapy in any herd.
Sodium Salicyl 80% can be administered orally through the milk replacer or drinking water. Orally administered salicylates are absorbed rapidly and make it easier to treat groups of pigs and calves suffering from stress.
Vetoquinol says it's well known that any focus of pain or discomfort is likely to reduce an animals' feed and water intake, enough to reduce performance and potentially increase the need for the use of antibiotics. NSAID's are ideal for use in times of stress, for example after weaning where they have the ability to reduce inflammation, provide analgesia and reduce pyrexia. Unlike corticosteroids, NSAID's relieve pain and inflammation without the immunosuppressive and metabolic side effects. Stress is a known cause for an acute phase response (inflammation) and viral and bacterial infections are common in this vulnerable period.
Susan Mitchell, Large Animal Product Manager at Vetoquinol said: 'We are delighted to be expanding our large animal range with Sodium Salicyl 80%. We are now able to offer vets and producers a solution for both individual and group situations where an NSAID is required"
Clinicians at the Queen Mother Hospital for Animals at the Royal Veterinary College have become the first team in the UK to successfully treat acromegaly in a cat with hypophysectomy surgery.
According to the RVC, this make it the first centre in the UK, and only the fourth in the world, to offer this procedure. The patient groups that might benefit from this RVC-exclusive procedure include cats and dogs with non-functional pituitary tumors, cats and dogs with hyperadrenocorticism (Cushing's disease) and cats with acromegaly or hypersomatotropism.
The RVC says removing the pituitary gland and the associated tumour which causes acromegaly or hyperadrenocorticism is the gold standard treatment in humans suffering from these diseases since it offers the greatest chance of a complete cure for the disease.
Prior to the RVC offering surgical treatment, the only treatment options available for acromegalic cats in the UK were radiation therapy or simply treatment of the resulting diabetes mellitus. The latter can prove extremely difficult and frustrating and the former unpredictable, unreliable and/or ineffective. Even when a complete response to the radiation therapy eventually occurs, hormonal abnormalities usually persist.
Dr Stijn Niessen, leading the hypophysectomy team at the Royal Veterinary College, said: "I'm extremely proud to be able to offer this unique surgery for the first time in the UK at the RVC. As a relatively new and innovative procedure in veterinary medicine there are risks involved, as is recognised with every form of neurosurgery of this level. However, despite these risks, this surgery does offer owners a chance for the best possible result for their pet using a single procedure. Hypophysectomy therefore represents the most elegant treatment method currently available enabling complete removal of the brain tumor and normalisation of damaging excessive hormone levels that are causing hormonal diseases like acromegaly and hyperadrenocorticism.
"Especially when a pituitary tumor is diagnosed late, the alternative treatment method of radiation therapy might well take too long to take effect and devastating neurological signs might occur due to the pressure of the pituitary tumor on the surrounding brain. In such cases, hypophysectomy can make an instant difference in relieving that pressure. However, in general, we would advocate the procedure to be considered as soon as possible following diagnosis, thereby preventing the animal's body from becoming more and more negatively affected by the excessive hormone levels associated with pituitary diseases like acromegaly and hyperadrenocorticism."
Dr. Niessen, a European Veterinary Specialist in Internal Medicine with research interests in diabetes and endocrinology and world-expert in acromegaly, will be selecting the patients suitable for the new treatment, preparing them for surgery and managing the aftercare programme. The longer-term aftercare programme will include hormone replacement treatment administered through eye-drops (usually temporarily) and tablets (permanent) to manage the hormone production lost through removal of the pituitary gland.
The surgery itself will be performed by Patrick Kenny, a European and American Specialist in Veterinary Neurology and Neurosurgery.
The RVC says the surgery would not be possible without the multidisciplinary approach at the Queen Mother Hospital for Animals, which includes the Internal Medicine, Neurology and Neurosurgery, Diagnostic Imaging, Anaesthesia and Emergency and Critical Care teams as well as a team of highly qualified nurses.
To support ongoing research in this field, the Royal Veterinary College is offering free blood tests for all diabetic dogs and cats which include fructosamine evaluation and screening tests for the presence of acromegaly in cats. Cats that record high hormone levels indicative of acromegaly will qualify to undergo a free CT scan for confirmation. If acromegaly is confirmed, all possible treatment options will be discussed with the client, including the hypophysectomy procedure. To request a free blood test for a patient please visit: www.rvc.ac.uk/cic
Veterinary surgeons currently managing a cat or dog with a pituitary tumor who are considering referral of this case can also contact Dr Stijn Niessen for further information at the QMHA on 01707 666365 or at qmhreception@rvc.ac.uk
Mr Seymour-Hamilton was originally removed from the Register following an inspection of his Kent practice in 1993 which found that his operating theatre “showed a total disregard of basic hygiene and care for animals and was such as to bring the profession into disrepute”.
Since being removed from the Register, Mr Seymour-Hamilton has made applications for restoration in 1995, 2010, 2015, 2016, 2017, 2018 and 2019. Each was rejected.
In his latest application, Mr Seymour-Hamilton said that he did not want to re-join the Register in order to practise but to facilitate his research in the area of herbal medicine.
The Committee found that while Mr Seymour-Hamilton had accepted some of the findings of the original case, he disagreed with important facts, such as whether or not his surgery was open at the time of the inspection, and showed ‘minimal insight’ into the seriousness of the findings.
The Committee also voiced concerns over public protection and animal welfare should he be restored, saying that he had demonstrated little or no understanding of the purpose of regulation. The Committee also noted that he had, by his own admission, spayed two cats at a practice in Calais in recent years despite his long absence from the Register and unregistered status as a veterinary surgeon in the UK or France.
In considering his conduct since leaving the Register, the Committee found that Mr Seymour-Hamilton had admitted to a number of instances of conduct which it found ‘reprehensible’. This included carrying out spays; not self-isolating after testing positively for coronavirus and, in fact, travelling through France and Spain in breach of the lockdown put in place due to the pandemic; deliberately trying to re-infect himself with coronavirus and then visiting a vulnerable person without maintaining social distancing; treating his own animals with untested herbal remedies; and using his own remedies to treat people, which, in one case, included a nine-year-old boy in Greece.
In summing up Judith Way, who was chairing the Committee and speaking on its behalf, said: “The Committee has concluded that he has not satisfied it that he is fit to be restored to the Register. He has exhibited a disregard for regulation and compliance with the law. He lacks an understanding as to why he has not been restored in the past. He has not set about addressing any of his shortcomings. He relies wholeheartedly on his research, yet he does not support that research with any real peer-reviewed publications and he fails to acknowledge the consequences of being out-of-practice for so long. He has misplaced confidence in his own abilities and does not recognise that his approach and/or actions can represent a danger to animals and to the public. The Committee has therefore reached the conclusion that the applicant is not a fit person to be restored to the Register.”
The full findings of the restoration hearing for Mr Seymour-Hamilton can be found at: www.rcvs.org.uk/disciplinary
The Mercury Challenge, which is being conducted by Ceva Animal Health, aims to collect data on 10,000 cats across Europe to provide a new insight into the detection and management of feline hypertension, a frequent and severe condition that is still not routinely checked1.
Vets participating in the initiative need to input five mandatory pieces of information at mercurychallenge.ceva.com: the owner’s name, cat’s name, age, systolic blood pressure and time spent measuring blood pressure. Additional information includes: weight, breed, sex and whether the animal has any concurrent diseases, such as chronic kidney disease or hyperthyroidism, or is on any treatments.
Participating practices will be given exclusive access to the study’s progression and results, as well as acknowledgements for their contribution to the Mercury Challenge, depending on the number of cats entered.
Imane Mahlous, cardiology-nephrology and hypertension product manager at Ceva Animal Health said: "It is quick and easy to take part in the Mercury Challenge, which we hope will revolutionise the way that feline hypertension is understood and treated by both cat owners and veterinary professionals."
For information on feline hypertension or the Mercury Challenge, contact your local Ceva Animal Health account manager or visit mercurychallenge.ceva.com.
A survey carried out by the company in 20151 found that 46% of dog owners were not aware that dogs can potentially suffer from the condition, despite the fact that it affects an estimated 375,000 dogs in the UK.3
The company says ocular conditions account for around one in ten canine consultations in first opinion practice,2 with KCS affecting around 5% of all dogs3, and up to 20% of predisposed breeds.4
To help raise owner awareness, Bayer will be holding the first veterinary Dry Eye Awareness Month in July.
Because early diagnosis and treatment can have a significant impact on prognosis, the focus of the campaign will be on encouraging pet owners to speak to their veterinary surgeon in the hope of increasing early diagnoses and improving the uptake of regular testing of at-risk breeds.
The campaign will include a dedicated social media element, targeting communities of at-risk breeds by inviting them to pledge their commitment to managing dry eye in their pet. A range of practice materials have also been produced for practices to support the drive in their waiting room.
Hannah Watts, Group Product Manager at Bayer said: "With this significant gap in owner understanding of the significance of KCS in dogs, it was clear that more is needed to be done to encourage owners of at-risk breeds to visit their vet practice for early diagnosis.
"The focus of Dry Eye Awareness Month is to support vets in championing the issue amongst their client base, through a range of educational materials. We hope vets will join us in utilising the month as a platform on which to discuss the prevalence and potential seriousness of the condition if left unmanaged."
Bayer’s research also found how poor understanding of the lifelong nature of the condition is one of the main barriers to owner compliance when managing cases, further highlighting the need for education.5
Chris Dixon, Director at Veterinary Vision Ophthalmic Referrals, said: "KCS cases can present acutely, or with subtle clinical signs that will not be detected from initial observations and require a Schirmer tear test to effectively quantify the reflex tear film production. Unless vets are actively discussing the condition with owners, and performing these tests on a regular basis, it is likely that many dogs could remain undiagnosed."
"In any case where ongoing treatment is required, client education is key in successful disease management. Accurate determination of the cause of the KCS will allow for an appropriate choice of medical therapy. When adjunctive tear replacement therapy is required, many owners will admit to not having the time to administer treatments frequently enough, which should factor into the recommendations we make as practitioners. For example, offering a longer acting product which requires less frequent application.”
You can download the Remend ‘Vision Matters – A Focus on Keratoconjunctivitis Sicca’ educational guide for veterinary surgeons here: www.remend.co.uk/vets-area.
Dry Eye Awareness Month practice display materials can be ordered from your Bayer Territory Manager or email: ahmarketing@bayer.com
The removal of names from the RCVS Register of Veterinary Surgeons for non-payment of retention fees is now complete, with 386 veterinary surgeons having been removed, compared with 616 last year.
The RCVS says that the administration involved with removing a name for non-payment is time-consuming and costly. Hence, to be restored to the Register, the veterinary surgeon must pay the appropriate annual retention fee, and the restoration fee, currently £294, which multiplies each time if fees are not paid in successive years.
The College writes to members' Register addresses to remind them when fees are due and, where an email address is maintained by the member as part of their formal record, also sends an email. It is, however, the responsibility of members to inform the RCVS Registration Department of any changes to their contact details and to ensure that payment is made. It is illegal for veterinary surgeons to practise or undertake any veterinary-related activities if their name does not appear on the RCVS Register as a home-practising member.
To help ensure that members removed for non-payment are aware that they have been removed from the Register, the full list of those removed for non-payment and not restored by 10 June can be downloaded from RCVSonline. The current status of individual veterinary surgeons can be checked online (www.rcvs.org.uk/checkregister).
A veterinary surgeon whose name has been removed from the Register and who wishes to restore him or herself should view the information on restoration to the Register.
Alternatively, please ring the RCVS Registration Department on 020 7202 0707. Restorations made since 10 June are not shown on this list.
VetSurgeon is sad to report that Sam Duff, a much loved figure in the profession, died last weekend.
Sam qualified from Edinburgh in 1970, and was a partner in mixed practice in Fife until 2002. More recently, he was a director of Equitique Ltd, an equine reproduction referral practice.
Sam was an active member of BVA Council, and its Member Services Group. He served on SPVS Council from 1993-2002, and was re-elected in 2003. He had recently been elected as Secretary of the Scottish branch of the BVA.
A memorial service will be held at 2.30pm on Thursday 9th July in Younger Hall, St Andrews.
The Disciplinary Committee made its decision last Friday, following an adjournment of the case, which was initially heard in May of this year.
There were three heads of charge against Mr Hough:
The Committee found the majority of the first head of charge not proven, with the exception of the charges that Mr Hough failed to provide and ensure adequate overnight care for Mya and that it was inappropriate and unreasonable for him to plan for the wound management to be undertaken by Mya’s owners following the second procedure on 21 May 2014.
Regarding the second head of charge, the Committee found it proven that Mr Hough did fail to provide information about post-operative care and out-of-hours cover details to Mya’s owners. However it found Mr Hough’s failure to communicate with the owners regarding treatment options and to provide them with adequate information as to Mya’s post-operative condition not proven.
The third head of charge in its entirety was admitted and found proven.
The Committee also found that those charges that were found proven amounted to disgraceful conduct in a professional respect with the exception of Mr Hough’s failure to provide and/or ensure adequate overnight care and his failure to failure to provide out-of-hours details to Mya’s owners.
In deciding on an appropriate sanction, the Committee expressed significant concerns over Mr Hough’s treatment of Mya, in particular his "failure to devise and implement proper and sufficient procedures to ensure that this dog was not released to owners unless it was safe for her to be released and... that the owners were fully advised as to what was required of them."
The Committee felt that Mr Hough had given "insufficient attention" to Mya’s post-operative care but did accept that the conduct represented a single incident. During the course of the hearing the Committee also heard mitigating evidence given on behalf of Mr Hough, with a number of written testimonials as well as witness evidence in support of his clinical expertise and surgical skills.
The Committee accepted that Mr Hough had taken to heart the lessons to be learnt from the charges against him and had implemented a number of written protocols to prevent recurrence of the shortcomings in his treatment of Mya. Furthermore, the Committee also found that Mr Hough had demonstrated insight into the conduct found against him and that he had apologised for the disparaging remarks he made about other veterinary practitioners.
Alistair Barr, chairing the Disciplinary Committee and speaking on its behalf, said: "In short, the Committee is persuaded that Mr Hough has made a good start in putting in place systems to ensure that the interests and welfare of the animals treated at his practice surgeries are not discharged from care until they are fully ready to be discharged and that the owners of such animals will, in future, be fully informed of what might be asked and required of them when their animals are returned into their care after surgery."
He added: "There are no other areas of [Mr Hough’s] professional practices which appear to the Committee to call for improvements. Accordingly, the Committee is persuaded on this evidence that there is reason to believe that the lessons which Mr Hough needed to learn have been learnt and concludes, therefore, that the sanction of a formal and solemn reprimand adequately meets the needs of the public interest in, and requirements of, this particular case. Mya did make a full recovery from her extensive surgery but she and her owners deserved better post-surgery advice and support."
All practices are eligible to register and no FCA authorisation is needed.
Carefree Credit says it will also process applications to make practice administration hassle free.
Mike Aldred, Director at Carefree Credit, said: "With the deepening cost of living crisis, owning a pet has never been more expensive for many pet owners and having these longer terms available will really help their pets get the treatment they need."
To register your practice with Carefree Credit, email office@carefreecredit.co.uk or call 0345 313 0177.
https://www.carefreecredit.co.uk